{"id":19910,"date":"2023-08-15T21:37:00","date_gmt":"2023-08-15T18:37:00","guid":{"rendered":"https:\/\/stage.www.cobalt.legal\/?p=19910"},"modified":"2023-08-15T21:37:00","modified_gmt":"2023-08-15T18:37:00","slug":"cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio","status":"publish","type":"post","link":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/","title":{"rendered":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Daugelyje Europos valstybi\u0173 i\u0161 kanapi\u0173 ekstrakto i\u0161gaunamo junginio kanabidiolio (CBD) pagrindu gaminam\u0173 produkt\u0173 populiarumas ir pardavimai auga. Ta\u010diau santykinai neseniai atsiradusio verslo atstovai reklamuodami savo produkcij\u0105 neretai klysta \u2013 pardavim\u0173 stiprinimui parenka netinkamus rinkodaros teiginius, kurie, \u0161iuo metu galiojan\u010di\u0173 teis\u0117s akt\u0173 vertinimu, gali suklaidinti vartotoj\u0105. \u0160tai visai neseniai Valstybin\u0117 vartotoj\u0173 teisi\u0173 apsaugos tarnyba (VVTAT) u\u017e CBD produkt\u0173 klaidinan\u010dios reklamos skleidim\u0105 \u012fmones <a href=\"https:\/\/www.vvtat.lt\/naujienos-ir-pranesimai-ziniasklaidai\/377\/skirtos-baudos-uz-klaidinancia-cbd-produktu-reklama:2575\">apdalino baudomis<\/a>.\u00a0 <\/strong><\/p>\n<p style=\"text-align: justify;\">Pagal dabartin\u0119 Europos S\u0105jungos teisin\u0119 sistem\u0105 ir atsi\u017evelgiant \u012f Teisingumo Teismo jurisprudencij\u0105, valstybi\u0173 nari\u0173 nacionalin\u0117s vald\u017eios institucijos yra atsakingos u\u017e kiekvieno atitinkamo produkto savybi\u0173 \u012fvertinim\u0105 bei nustatym\u0105, ar produktas atitinka vaistinio preparato ar maisto produkto reikalavimus.\u00a0 Kiekvienu konkre\u010diu atveju atsi\u017evelgiama \u012f visas produkto savybes, taip pat \u012f jo sud\u0117t\u012f, farmakologines savybes, kurios gali b\u016bti nustatytos remiantis turimais mokslo duomenimis, vartojimo b\u016bd\u0105, platinimo apimt\u012f, vartotoj\u0173 turim\u0105 informacij\u0105 apie j\u012f ir gr\u0117smes, kurias gali sukelti jo vartojimas.<\/p>\n<p style=\"text-align: justify;\">Taigi, Europos S\u0105jungoje teiginiai, jog produktas gali \u201eu\u017ekirsti keli\u0105 ligai\u201c, \u201ej\u0105 gydyti\u201c, \u201eapsaugo nerv\u0173 sistem\u0105, gydo nerv\u0173 ligas\u201c, \u201epa\u0161alina nuovargio jausm\u0105\u201c ir kt., gali b\u016bti naudojami tik kalbant apie vaistus. Ta\u010diau \u0161iai produkt\u0173 grupei galioja ir kiti itin grie\u017eti reikalavimai: norint jais prekiauti reikalingi atitinkami leidimai, b\u016btina registracija, ai\u0161ki informacija apie dozavim\u0105, vartojimo b\u016bd\u0105, perdozavim\u0105, specialius \u012fsp\u0117jimus ir kt.<\/p>\n<p style=\"text-align: justify;\">VVTAT verslininkams, reklamuojantiems CBD produktus, yra parengusi atmintin\u0119, kurioje sura\u0161yti teis\u0117s akt\u0173 nuostatas pa\u017eeid\u017eiantys teiginiai, naudojami CBD produkt\u0173 reklamoje. Pvz., siekiant pabr\u0117\u017eti aliejaus, kremo, la\u0161iuk\u0173, kapsuli\u0173 su CBD naud\u0105, n\u0117ra tinkami tokie teiginiai, kaip \u201e<em>gerina savijaut\u0105\u201c, \u201eramina, padeda kovoti su stresu, ma\u017eina nerim\u0105, depresij\u0105\u201c, \u201eapsaugo nerv\u0173 sistem\u0105, gydo nerv\u0173 ligas<\/em>\u201c ir kt. Tokie teiginiai kaip <em>\u201ema\u017eina skausm\u0105, kraujosp\u016bd\u012f, s\u0105nari\u0173, raumen\u0173 skausm\u0105, atpalaiduoja\u201c, \u201eapsaugo od\u0105 nuo ilgalaiki\u0173 pa\u017eeidim\u0173\u201c, \u201egerina mieg\u0105, padeda nuo nemigos, gydo miego sutrikimus<\/em>\u201c ir pan., taip pat n\u0117ra tinkami CBD produkt\u0173 reklamoje.<\/p>\n<p style=\"text-align: justify;\">CBD produktais prekiaujan\u010dios bendrov\u0117s, siekdamos pagr\u012fsti reklamoje naudojam\u0173 teigini\u0173 teisingum\u0105, da\u017enai remiasi moksliniais tyrimais, kuriuose ra\u0161oma apie kanabinoid\u0173 preparatus ir j\u0173 \u012fvairiapusi\u0161k\u0105 naud\u0105. \u0160iais tyrimais pardav\u0117jai grind\u017eia savo reklam\u0105. Taip pat pardav\u0117jai remiasi tuo, jog kai kurios kitos \u0161alys yra \u012fteisinusios CBD prekyb\u0105 bei taiko \u0161iuos produktus oficialioje medicinoje, preparatus skiria medikai bei psichoterapeutai.<\/p>\n<p style=\"text-align: justify;\">Ta\u010diau, pirma, svarbu pabr\u0117\u017eti, kad pardav\u0117jai per menkai \u012fsigilina, apie kokius konkre\u010diai produktus yra moksliniai straipsniai. Da\u017enu atveju cituojami moksliniai tyrimai n\u0117ra susij\u0119 su b\u016btent bendrov\u0117s reklamuojamais ir si\u016blomais \u012fsigyti CBD produktais. Be to, moksliniai straipsniai n\u0117ra klinikiniais tyrimais pagr\u012fsta informacija. Antra, jeigu bendrov\u0117s prekiauja gaminiais, kurie n\u0117ra registruoti nei kaip vaistiniai preparatai, nei kaip medicinos priemon\u0117s Lietuvos ar Bendrijos vaistini\u0173 preparat\u0173 registruose ir\/ar gauti atitinkami leidimai, n\u0117ra svarbu, jog kitos valstyb\u0117s yra \u012fteisinusios CBD prekyb\u0105 ir naudoja juos oficialioje medicinoje.<\/p>\n<p style=\"text-align: justify;\">VVTAT taip pat pa\u017eymi, jog jeigu atlikus klinikinius konkre\u010di\u0173 gamini\u0173 tyrimus paai\u0161k\u0117t\u0173 j\u0173 terapinis, gydomasis poveikis, tokie produktai tur\u0117t\u0173 b\u016bti teikiami \u012f rink\u0105 kaip vaistiniai preparatai arba medicinos priemon\u0117s su visais papildomais jiems taikomais reikalavimais.<\/p>\n<p style=\"text-align: justify;\">Maisto produkt\u0173 ar papild\u0173 reklamoje draud\u017eiama u\u017esiminti apie \u017emogaus lig\u0173 gydymo ar profilaktines savybes. Maisto produktai, kaip ir kosmetikos gaminiai, n\u0117ra vaistiniai preparatai, tod\u0117l negali b\u016bti reklamuojami nurodant vaistinio preparato savybes. Taigi, teigini\u0173 apie gydom\u0105j\u012f\/prevencin\u012f poveik\u012f naudojimas reklamuojant produktus, kurie n\u0117ra vaistai, gali pa\u017eeisti LR Reklamos \u012fstatymo ar Nes\u0105\u017einingos veiklos draudimo \u012fstatymo nuostatas. Toki\u0173 teigini\u0173 naudojimas gali b\u016bti laikomas Reklamos \u012fstatyme \u012ftvirtintu klaidinan\u010dios reklamos draudimo pa\u017eeidimu.<\/p>\n<p style=\"text-align: justify;\">Klaidinanti reklama \u2013 reklama, kuri bet kokiu b\u016bdu, \u012fskaitant ir jos pateikimo b\u016bd\u0105, klaidina arba gali suklaidinti asmenis, kuriems ji skirta arba kuriuos ji pasiekia, ir kuri d\u0117l savo klaidinan\u010dio pob\u016bd\u017eio gali paveikti j\u0173 ekonomin\u012f elges\u012f arba kuri d\u0117l \u0161i\u0173 prie\u017eas\u010di\u0173 pakenkia ar gali pakenkti kito asmens galimyb\u0117ms konkuruoti. Pavyzd\u017eiui, pamat\u0119 tokius reklaminius teiginius vartotojai gali nepagr\u012fstai tik\u0117tis, jog CBD produktas pad\u0117s \u012fveikti nerimo ar depresijos sutrikimus ar veiks kaip prevencin\u0117 priemon\u0117. Vartotojai, sergantys reklamoje minimomis ligomis, toki\u0105 informacij\u0105 gali vertinti jautriau nei toki\u0173 sutrikim\u0173 neturintys asmenys, d\u0117l to gali b\u016bti patiklesni reklamos skleid\u017eiamai informacijai. U\u017e Lietuvos Respublikos reklamos \u012fstatymo pa\u017eeidim\u0105 ar nes\u0105\u017eining\u0105 komercin\u0119 veikl\u0105 gali b\u016bti skiriama bauda iki 100 000 Eur, bet ne daugiau nei 3 procent\u0173 pa\u017eeid\u0117jo metini\u0173 pajam\u0173 pra\u0117jusiais finansiniais metais.<\/p>\n<p style=\"text-align: justify;\">Svarbu pamin\u0117ti ir tai, kad jeigu CBD produktai yra notifikuoti kosmetikos produktai, jie turi b\u016bti naudojami i\u0161imtinai i\u0161orin\u0117ms \u017emogaus k\u016bno dalims (epidermiui, plaukams, nagams, l\u016bpoms ir i\u0161oriniams lyties organams) arba dantims ar burnos ertm\u0117s gleivinei, norint tik (arba daugiausiai) valyti, kv\u0117pinti, pakeisti i\u0161vaizd\u0105, apsaugoti, i\u0161laikyti j\u0173 ger\u0105 b\u016bkl\u0119 arba pa\u0161alinti k\u016bno kvapus. Jeigu CBD produkto reklamoje ar naudojimo instrukcijoje nurodomas kitoks galimas vartojimo b\u016bdas, tokia komercin\u0117 praktika gali tur\u0117ti ne tik klaidinan\u010dios reklamos, bet ir nes\u0105\u017einingos komercin\u0117s veiklos po\u017eymi\u0173. Be kita ko, pagal galiojan\u010dius teis\u0117s aktus, \u017eenklinant, pateikiant rinkai ir reklamuojant kosmetikos gaminius draud\u017eiama naudoti formuluotes, pavadinimus, prek\u0117s \u017eenklus, vaizdinius ar kitus \u017eenklus, kurie perkeltine ar kita prasme \u012fteigt\u0173, kad gaminiai turi savybi\u0173 arba funkcij\u0173, o b\u016btent \u2013 gydom\u0173j\u0173 ir profilaktini\u0173 savybi\u0173, kuri\u0173 i\u0161 ties\u0173 neturi.<\/p>\n<p style=\"text-align: justify;\">Pagal \u201eGoogle\u201c ir \u201eMeta\u201c (\u201eFacebook\u201c valdytoj\u0173) CBD reklam\u0173 politik\u0105, svetain\u0117 ir visi joje si\u016blomi CBD produktai turi b\u016bti sertifikuoti pagal <em>LegitScript sertifikavimo program\u0105<\/em>. Tai rei\u0161kia, kad \u201eGoogle\u201c, vertindama svetain\u0117s tinkamum\u0105 \u201eGoogle Ads\u201c platformai, nepatvirtins svetain\u0117s, kurioje yra naudojami raktiniai \u017eod\u017eiai \u201eCannabidiol\u201c arba CBD, i\u0161skyrus atvejus, kai bus reklamuojamas i\u0161ori\u0161kai naudojamas CBD produktas arba patvirtintos farmacin\u0117s paskirties CBD. Visa paskyra bus patikrinta ir, nusta\u010dius \u0161io reikalavimo pa\u017eeidimus, gali b\u016bti visam laikui sustabdyta. \u0160is reikalavimas taikomas el. prekybos svetain\u0117ms, informacin\u0117ms svetain\u0117ms, tinklara\u0161\u010diams ir medijos svetain\u0117ms, susietoms su \u201eGoogle Ads\u201c paskyra. Be to, CBD produkt\u0173 skelbimuose negali b\u016bti teigini\u0173, kad rodomi produktai gali gydyti, u\u017ekirsti keli\u0105 \u017emoni\u0173 ar gyv\u016bn\u0173 ligoms, kad yra skirti sveikatos b\u016bklei pagerinti, arba tinkami vartoti jaunesniems nei 18 met\u0173 asmenims bei yra leid\u017eiami Jungtin\u0117se Amerikos Valstijose.<\/p>\n<p style=\"text-align: justify;\">Nepaisant to, kad duomen\u0173 baz\u0117se gausu mokslini\u0173 tyrim\u0173, rodan\u010di\u0173 CBD produkt\u0173 naud\u0105 sprend\u017eiant \u012fvairias sveikatos problemas, \u0161ie produktai n\u0117ra registruoti vaistiniai preparatai ar medicinos priemon\u0117s. Praktika rodo, jog j\u0173 reklama m\u016bs\u0173 \u0161alyje yra grie\u017etai reguliuojama. D\u0117l to CBD prekyba u\u017esiimantys verslai, siekdami i\u0161vengti finansin\u0117s ir reputacin\u0117s \u017ealos, turi \u012fsivertinti tinkam\u0105 bei teis\u0117s akt\u0173 nuostatoms neprie\u0161taraujan\u010di\u0105 rinkodaros strategij\u0105.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Daugelyje Europos valstybi\u0173 i\u0161 kanapi\u0173 ekstrakto i\u0161gaunamo junginio kanabidiolio (CBD) pagrindu gaminam\u0173 produkt\u0173 populiarumas ir pardavimai auga. Ta\u010diau santykinai neseniai atsiradusio verslo atstovai reklamuodami savo produkcij\u0105 neretai klysta \u2013 pardavim\u0173 stiprinimui parenka netinkamus rinkodaros teiginius, kurie, \u0161iuo metu galiojan\u010di\u0173 teis\u0117s..<\/p>\n","protected":false},"author":6,"featured_media":19911,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[29],"country":[92],"class_list":["post-19910","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-lt","country-lithuania-lt"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio? | COBALT<\/title>\n<meta name=\"description\" content=\"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio? | COBALT\" \/>\n<meta property=\"og:description\" content=\"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?. News. Naujienos. Jaunumi. Uudised.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/\" \/>\n<meta property=\"og:site_name\" content=\"COBALT\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CobaltLegal\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-15T18:37:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/08\/5-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1050\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ilze Augstkalne\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ilze Augstkalne\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minut\u0117s\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/\"},\"author\":{\"name\":\"Ilze Augstkalne\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/person\\\/a96c052a2eba55b2f6b995c69436c3aa\"},\"headline\":\"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?\",\"datePublished\":\"2023-08-15T18:37:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/\"},\"wordCount\":1127,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/5-2.jpg\",\"articleSection\":[\"Uncategorized @lt\"],\"inLanguage\":\"lt-LT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/\",\"name\":\"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio? | COBALT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/5-2.jpg\",\"datePublished\":\"2023-08-15T18:37:00+00:00\",\"description\":\"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?. News. Naujienos. Jaunumi. Uudised.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/#breadcrumb\"},\"inLanguage\":\"lt-LT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/5-2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/5-2.jpg\",\"width\":1050,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/news-cases\\\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#website\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\",\"name\":\"COBALT\",\"description\":\"Top-tier law services in Estonia, Latvia and Lithuania\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lt-LT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#organization\",\"name\":\"COBALT\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cobalt.legal\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/cobalt-logo.png\",\"width\":400,\"height\":116,\"caption\":\"COBALT\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CobaltLegal\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/#\\\/schema\\\/person\\\/a96c052a2eba55b2f6b995c69436c3aa\",\"name\":\"Ilze Augstkalne\",\"url\":\"https:\\\/\\\/www.cobalt.legal\\\/lt\\\/author\\\/ilze\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio? | COBALT","description":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?. News. Naujienos. Jaunumi. Uudised.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/","og_locale":"lt_LT","og_type":"article","og_title":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio? | COBALT","og_description":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?. News. Naujienos. Jaunumi. Uudised.","og_url":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/","og_site_name":"COBALT","article_publisher":"https:\/\/www.facebook.com\/CobaltLegal\/","article_published_time":"2023-08-15T18:37:00+00:00","og_image":[{"width":1050,"height":700,"url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/08\/5-2.jpg","type":"image\/jpeg"}],"author":"Ilze Augstkalne","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ilze Augstkalne","Est. reading time":"6 minut\u0117s"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/#article","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/"},"author":{"name":"Ilze Augstkalne","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/person\/a96c052a2eba55b2f6b995c69436c3aa"},"headline":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?","datePublished":"2023-08-15T18:37:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/"},"wordCount":1127,"publisher":{"@id":"https:\/\/www.cobalt.legal\/lt\/#organization"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/08\/5-2.jpg","articleSection":["Uncategorized @lt"],"inLanguage":"lt-LT"},{"@type":"WebPage","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/","url":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/","name":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio? | COBALT","isPartOf":{"@id":"https:\/\/www.cobalt.legal\/lt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/#primaryimage"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/08\/5-2.jpg","datePublished":"2023-08-15T18:37:00+00:00","description":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?. News. Naujienos. Jaunumi. Uudised.","breadcrumb":{"@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/"]}]},{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/#primaryimage","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/08\/5-2.jpg","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/08\/5-2.jpg","width":1050,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/www.cobalt.legal\/lt\/news-cases\/cbd-produktu-prekeiviai-pratinasi-prie-rinkos-reikalavimu-kaip-neuzlipti-ant-greblio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cobalt.legal\/lt\/"},{"@type":"ListItem","position":2,"name":"CBD produkt\u0173 prekeiviai pratinasi prie rinkos reikalavim\u0173: kaip neu\u017elipti ant gr\u0117blio?"}]},{"@type":"WebSite","@id":"https:\/\/www.cobalt.legal\/lt\/#website","url":"https:\/\/www.cobalt.legal\/lt\/","name":"COBALT","description":"Top-tier law services in Estonia, Latvia and Lithuania","publisher":{"@id":"https:\/\/www.cobalt.legal\/lt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cobalt.legal\/lt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lt-LT"},{"@type":"Organization","@id":"https:\/\/www.cobalt.legal\/lt\/#organization","name":"COBALT","url":"https:\/\/www.cobalt.legal\/lt\/","logo":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/logo\/image\/","url":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","contentUrl":"https:\/\/www.cobalt.legal\/wp-content\/uploads\/2023\/04\/cobalt-logo.png","width":400,"height":116,"caption":"COBALT"},"image":{"@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CobaltLegal\/"]},{"@type":"Person","@id":"https:\/\/www.cobalt.legal\/lt\/#\/schema\/person\/a96c052a2eba55b2f6b995c69436c3aa","name":"Ilze Augstkalne","url":"https:\/\/www.cobalt.legal\/lt\/author\/ilze\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/19910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/comments?post=19910"}],"version-history":[{"count":1,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/19910\/revisions"}],"predecessor-version":[{"id":19915,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/posts\/19910\/revisions\/19915"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/media\/19911"}],"wp:attachment":[{"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/media?parent=19910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/categories?post=19910"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.cobalt.legal\/lt\/wp-json\/wp\/v2\/country?post=19910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}